We are live on ! Find out more
SBH

Segall Bryant & Hamill Portfolio holdings

AUM $6.98B
1-Year Est. Return 34.78%
This Fund
S&P 500
This Quarter Est. Return
+4.24%
1 Year Est. Return
+34.78%
3 Year Est. Return
+85.12%
5 Year Est. Return
+106.02%
10 Year Est. Return
+446.97%
AUM
$4.31B
AUM Growth
+$60.9M
Cap. Flow
-$73.3M
Cap. Flow %
-1.7%
Top 10 Hldgs %
16.36%
Holding
590
New
34
Increased
175
Reduced
265
Closed
22

Top Buys

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$26.3M
2
OKE icon
Oneok
OKE
+$18.5M
3
BAX icon
Baxter International
BAX
+$17.2M
4
AVY icon
Avery Dennison
AVY
+$12.8M
5
ICUI icon
ICU Medical
ICUI
+$11.8M

Top Sells

Rank Stock Value
1
AYI icon
Acuity Brands
AYI
+$23.3M
2
PPG icon
PPG Industries
PPG
+$22.4M
3
EFX icon
Equifax
EFX
+$19M
4
OKS
Oneok Partners LP
OKS
+$17.7M
5
MDT icon
Medtronic
MDT
+$17.5M

Sector Composition

Rank Sector Weight
1 Healthcare 17.99%
2 Industrials 16.07%
3 Financials 14.59%
4 Technology 13.97%
5 Consumer Discretionary 9.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IWF icon
476
iShares Russell 1000 Growth ETF
IWF
$119B
$349K 0.01%
11,148
+928
+9% +$28.4K
BXP icon
477
Boston Properties
BXP
$11.2B
$344K 0.01%
2,798
-388
-12% -$47K
NSC icon
478
Norfolk Southern
NSC
$76.1B
$344K 0.01%
2,605
+37
+1% +$4.5K
ESRX
479
DELISTED
Express Scripts Holding Company
ESRX
$343K 0.01%
5,416
-40
-0.7% -$2.49K
KSU
480
DELISTED
Kansas City Southern
KSU
$342K 0.01%
3,150
VIAV icon
481
Viavi Solutions
VIAV
$8.66B
$340K 0.01%
35,959
-361,775
-91% -$3.77M
MCK icon
482
McKesson
MCK
$104B
$338K 0.01%
2,200
-72
-3% -$11.2K
WMB icon
483
Williams Companies
WMB
$85.8B
$330K 0.01%
10,986
+1,791
+19% +$54.5K
ABB
484
DELISTED
ABB Ltd
ABB
$323K 0.01%
13,049
DOC icon
485
Healthpeak Properties
DOC
$15.7B
$322K 0.01%
11,560
+888
+8% +$26.7K
ULTA icon
486
Ulta Beauty
ULTA
$21.6B
$315K 0.01%
1,394
-75
-5% -$18.1K
NOC icon
487
Northrop Grumman
NOC
$78B
$314K 0.01%
1,092
GLW icon
488
Corning
GLW
$108B
$310K 0.01%
10,375
TFC icon
489
Truist Financial
TFC
$64.7B
$309K 0.01%
+6,582
New +$303K
ETR icon
490
Entergy
ETR
$52.4B
$307K 0.01%
8,042
+56
+0.7% +$2.17K
J icon
491
Jacobs Solutions
J
$16.6B
$307K 0.01%
6,359
-121
-2% -$5.41K
PLAY icon
492
Dave & Buster's
PLAY
$361M
$305K 0.01%
5,807
-808
-12% -$48.1K
NLY icon
493
Annaly Capital Management
NLY
$17.4B
$304K 0.01%
6,233
+1,725
+38% +$84.5K
SCHB icon
494
Schwab US Broad Market ETF
SCHB
$42.9B
$300K 0.01%
29,526
+888
+3% +$8.81K
AEP icon
495
American Electric Power
AEP
$72.4B
$296K 0.01%
4,219
+52
+1% +$3.7K
ADSK icon
496
Autodesk
ADSK
$50.1B
$292K 0.01%
2,597
CNI icon
497
Canadian National Railway
CNI
$78.3B
$290K 0.01%
3,505
-500
-12% -$40.5K
DEO icon
498
Diageo
DEO
$49.4B
$289K 0.01%
+2,190
New +$283K
SAP icon
499
SAP
SAP
$209B
$288K 0.01%
2,624
PFG icon
500
Principal Financial Group
PFG
$24.6B
$286K 0.01%
4,450

Similar funds

Segall Bryant & Hamill's Q3 2017 Portfolio in Review

As of Q3 2017, Segall Bryant & Hamill held 590 positions worth $4.31B, up 1.4% from $4.24B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Segall Bryant & Hamill's Q3 2017 filing shows 34 new, 175 increased, 265 reduced and 22 closed positions. Its largest new stake was ICU Medical: 67,735 shares worth $12.6M. The largest sale was Acuity Brands, an estimated $23.3M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 18% a quarter earlier, followed by Industrials and Financials.

  • Segall Bryant & Hamill's largest Q3 2017 buy was ICU Medical: 67,735 shares worth $12.6M.
  • Segall Bryant & Hamill added most to Thermo Fisher Scientific in Q3 2017, an estimated $26.3M increase.
  • Segall Bryant & Hamill's biggest Q3 2017 reduction was Acuity Brands, cutting an estimated $23.3M.
  • Segall Bryant & Hamill fully exited Oneok Partners LP in Q3 2017, selling an estimated $17.7M.
  • Segall Bryant & Hamill's ten largest holdings make up 16% of its $4.31B portfolio in Q3 2017.
  • Segall Bryant & Hamill opened 34 new positions and closed 22 in Q3 2017.
  • Segall Bryant & Hamill's portfolio value rose 1.4% quarter-over-quarter to $4.31B.

Based on Segall Bryant & Hamill's 13F filing for Q3 2017, filed 14 Nov 2017.